Evidence map›Paper›PMID 28728140›Full record

ArticleEnvironmental health perspectives2017

Effects of Inorganic Arsenic, Methylated Arsenicals, and Arsenobetaine on Atherosclerosis in the Mouse Model and the Role of As3mt-Mediated Methylation.

Luis Fernando Negro Silva, Maryse Lemaire, Catherine A Lemarié, Dany Plourde, Alicia M Bolt, Christopher Chiavatti, D Scott Bohle, Vesna Slavkovich, Joseph H Graziano, Stéphanie Lehoux and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Risk assessment of complex organoarsenic species in food.EFSA journal. European Food Safety Authority · 2024
    Article
  6. Risk assessment of small organoarsenic species in food.EFSA journal. European Food Safety Authority · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Arsenic and cancer: Evidence and mechanisms.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Rare, Protein-Altering Variants inEnvironmental health perspectives · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Luis Fernando Negro SilvaLady Davis Institute for Medical Research
Maryse LemaireLady Davis Institute for Medical Research
Catherine A LemariéLady Davis Institute for Medical Research
Dany PlourdeLady Davis Institute for Medical Research
Alicia M BoltLady Davis Institute for Medical Research
Christopher ChiavattiLady Davis Institute for Medical Research
D Scott BohleDepartment of Chemistry, McGill University, Montréal, Québec, Canada
Vesna SlavkovichMailman School of Public Health, Columbia University, New York, New York, USA
Joseph H GrazianoMailman School of Public Health, Columbia University, New York, New York, USA
Stéphanie LehouxLady Davis Institute for Medical Research
Koren K MannLady Davis Institute for Medical Research
Institute for Medical Research · MYColumbia University · USMcGill University · CA

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Perkin-Elmer NexION-300D Inductively Coupled Mass Spectrometer (ICP-MS)S10OD016384 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRAZIANO, JOSEPH H · 2014 to 2014
$181k
CIHR MOP – 115000NIEHS NIH HHS P30 ES009089NIH HHS S10 OD016384
6 · The paper itself

Abstract

backgroundArsenic is metabolized through a series of oxidative methylation reactions by arsenic (3) methyltransferase (As3MT) to yield methylated intermediates. Although arsenic exposure is known to increase the risk of atherosclerosis, the contribution of arsenic methylation and As3MT remains undefined.

objectivesOur objective was to define whether methylated arsenic intermediates were proatherogenic and whether arsenic biotransformation by As3MT was required for arsenic-enhanced atherosclerosis.

methodsWe utilized the

resultsWe found that methylated arsenicals, but not arsenobetaine, are proatherogenic and that As3MT is required for arsenic to induce reactive oxygen species and promote atherosclerosis. Importantly, As3MT was expressed and functional in multiple plaque-resident cell types, and transplant studies indicated that As3MT is required in extrahepatic tissues to promote atherosclerosis.

conclusionTaken together, our findings indicate that As3MT acts to promote cardiovascular toxicity of arsenic and suggest that human

Indexed as

Gene ExpressionAnimalsArsenicArsenicalsAtherosclerosisHumansMaleMethylationMethyltransferasesMiceMice, KnockoutWater Pollutants, ChemicalArsenicArsenicalsAS3MT protein, mouseMethyltransferasesWater Pollutants, Chemical

Identifiers

PMID28728140
PMCPMC5744679
OpenAlexW2738798374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.